- $122.27m
- -$40.55m
- CNY922.20m
- 86
- 91
- 87
- 99
Annual balance sheet for Ihuman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 862 | 855 | 1,050 | 1,214 | 1,169 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 78.3 | 59 | 81.9 | 62.6 | 54.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,021 | 1,015 | 1,254 | 1,382 | 1,336 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.9 | 50.5 | 22 | 9.82 | 18.4 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,047 | 1,101 | 1,333 | 1,450 | 1,420 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 399 | 483 | 561 | 491 | 448 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 404 | 493 | 564 | 493 | 459 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 643 | 608 | 769 | 958 | 961 |
| Total Liabilities & Shareholders' Equity | 1,047 | 1,101 | 1,333 | 1,450 | 1,420 |
| Total Common Shares Outstanding |